Works matching AU Patel, Sapna

Results: 107
    1
    2

    Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

    Published in:
    Oncologist, 2023, v. 28, n. 8, p. 714, doi. 10.1093/oncolo/oyad039
    By:
    • Nardo, Mirella;
    • Yilmaz, Bulent;
    • Nelson, Blessie Elizabeth;
    • Torres, Harrys A;
    • Wang, Lan Sun;
    • Granwehr, Bruno Palma;
    • Song, Juhee;
    • Pria, Hanna R F Dalla;
    • Trinh, Van A;
    • Oliva, Isabella C Glitza;
    • Patel, Sapna P;
    • Tannir, Nizar M;
    • Kaseb, Ahmed Omar;
    • Altan, Mehmet;
    • Lee, Sunyoung S;
    • Miller, Ethan;
    • Zhang, Hao;
    • Stephen, Bettzy A;
    • Naing, Aung
    Publication type:
    Article
    3
    4
    5
    6

    Fat embolism: Evolution of histopathological changes in the rat lung.

    Published in:
    Journal of Orthopaedic Research, 2010, v. 28, n. 2, p. 191, doi. 10.1002/jor.20963
    By:
    • McIff, Terence E.;
    • Poisner, Alan M.;
    • Herndon, Betty;
    • Lankachandra, Kamani;
    • Schutt, Shane;
    • HaileSelassie, Berekeetab;
    • Patel, Sapna;
    • Quinn, Tim;
    • Adler, Federico;
    • Molteni, Agostino
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Follicular helper T cell signature in type 1 diabetes.

    Published in:
    2015
    By:
    • Kenefeck, Rupert;
    • Chun Jing Wang;
    • Kapadi, Tauseef;
    • Wardzinski, Lukasz;
    • Attridge, Kesley;
    • Clough, Louise E.;
    • Heuts, Frank;
    • Kogimtzis, Alexandras;
    • Patel, Sapna;
    • Rosenthal, Miranda;
    • Masahiro Ono;
    • Sansom, David M.;
    • Narendran, Parth;
    • Walker, Lucy S. K.;
    • Wang, Chun Jing;
    • Kogimtzis, Alexandros;
    • Ono, Masahiro
    Publication type:
    journal article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Beyond BRAF<sup>V600</sup>: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma.

    Published in:
    Journal of Investigative Dermatology, 2015, v. 135, n. 2, p. 508, doi. 10.1038/jid.2014.366
    By:
    • Siroy, Alan E;
    • Boland, Genevieve M;
    • Milton, Denái R;
    • Roszik, Jason;
    • Frankian, Silva;
    • Malke, Jared;
    • Haydu, Lauren;
    • Prieto, Victor G;
    • Tetzlaff, Michael;
    • Ivan, Doina;
    • Wang, Wei-Lien;
    • Torres-Cabala, Carlos;
    • Curry, Jonathan;
    • Roy-Chowdhuri, Sinchita;
    • Broaddus, Russell;
    • Rashid, Asif;
    • Stewart, John;
    • Gershenwald, Jeffrey E;
    • Amaria, Rodabe N;
    • Patel, Sapna P
    Publication type:
    Article
    31
    32

    An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.

    Published in:
    OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1984059
    By:
    • Hasanov, Merve;
    • Milton, Denái R.;
    • Sharfman, William H.;
    • Taback, Bret;
    • Cranmer, Lee D.;
    • Daniels, Gregory A.;
    • Flaherty, Lawrence;
    • Hallmeyer, Sigrun;
    • Milhem, Mohammed;
    • Feun, Lynn;
    • Hauke, Ralph;
    • Doolittle, Gary;
    • Gregory, Nancy;
    • Patel, Sapna
    Publication type:
    Article
    33

    Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.

    Published in:
    OncoImmunology, 2016, v. 5, n. 3, p. 1, doi. 10.1080/2162402X.2015.1136044
    By:
    • Cooper, Zachary A.;
    • Reuben, Alexandre;
    • Spencer, Christine N.;
    • Prieto, Peter A.;
    • Austin-Breneman, Jacob L.;
    • Jiang, Hong;
    • Haymaker, Cara;
    • Gopalakrishnan, Vancheswaran;
    • Tetzlaff, Michael T.;
    • Frederick, Dennie T.;
    • Sullivan, Ryan J.;
    • Amaria, Rodabe N.;
    • Patel, Sapna P.;
    • Hwu, Patrick;
    • Woodman, Scott E.;
    • Glitza, Isabella C.;
    • Diab, Adi;
    • Vence, Luis M.;
    • Rodriguez-Canales, Jaime;
    • Parra, Edwin R.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.

    Published in:
    Cancers, 2020, v. 12, n. 8, p. 2270, doi. 10.3390/cancers12082270
    By:
    • Hasanov, Merve;
    • Rioth, Matthew J.;
    • Kendra, Kari;
    • Hernandez-Aya, Leonel;
    • Joseph, Richard W.;
    • Williamson, Stephen;
    • Chandra, Sunandana;
    • Shirai, Keisuke;
    • Turner, Christopher D.;
    • Lewis, Karl;
    • Crowley, Elizabeth;
    • Moscow, Jeffrey;
    • Carter, Brett;
    • Patel, Sapna
    Publication type:
    Article
    42
    43

    Adjuvant Ipilimumab in High-Risk Uveal Melanoma.

    Published in:
    Cancers, 2019, v. 11, n. 2, p. 152, doi. 10.3390/cancers11020152
    By:
    • Fountain, Eric;
    • Bassett, Roland L.;
    • Cain, Suzanne;
    • Posada, Liberty;
    • Gombos, Dan S.;
    • Hwu, Patrick;
    • Bedikian, Agop;
    • Patel, Sapna P.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Considerations in As analysis and speciation

    Published in:
    Journal: American Water Works Association, 1998, v. 90, n. 3, p. 103, doi. 10.1002/j.1551-8833.1998.tb08402.x
    By:
    • Edwards, Marc;
    • Taylor, Howard E.;
    • Antweiler, Ronald C.;
    • Eaton, Andrew D.;
    • Chen, Hsiao-wen;
    • Frey, Michelle;
    • NcNeill, Laurie;
    • Patel, Sapna
    Publication type:
    Article